Viewpoints to consider in the development of MLC and IMRT programs.

Abstract

Operational and administrative considerations for the development and implementation of either multileaf collimation (MLC) or non-MLC-based intensity-modulated radiation therapy (IMRT) will be discussed with respect to the impact that this will have on a radiation oncology department. The methodologies that are used in the development process will be reviewed in both the operational and administrative components. Operational issues addressing the potential clinical impact the department will experience, along with the beneficial outcome for the patients, will be major points in this review process. Administrative considerations generally focus on the financial impact that the department and hospital will have to deal with in determining cost benefits of this capital expenditure. This overview will focus on some key discussion points with the incorporation of MLC and IMRT into a radiation oncology department treatment program.